Susan Rux, RN, of Fox Chase Cancer Center, leads federally funded research to expand clinical trial access for underrepresented kidney cancer patients while mentoring the next generation of oncology ...

A Department of Defense–funded initiative targets underrepresented kidney cancer populations to improve clinical trial participation and address persistent disparities in access to novel therapies.

Demonstrates mastery of cytokine-stimulating immunotherapy protocols, coordinating admissions, monitoring, and protocol-driven assessments with meticulous attention to detail and proactive ...

Get expert answers to the top pancreatic cancer questions, including symptoms, surgery, new treatments, hereditary risk and early diagnosis.

Navigating a cancer diagnosis often begins with a simple online search. The new Cancer Search Bar series from CURE brings those commonly searched questions directly to oncology ex ...

FDA authorized Tregzi for adults with acute leukemia, MDS, and other hematologic malignancies receiving closely matched donor ...

AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...

Demonstrates rare patient-centered communication, consistently earning trust, de-escalating conflict, and advocating for comfort and dignity across inpatient and outpatient oncology settings. Brings ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Inclusive leadership is demonstrated through consistent respect, psychological safety, and communication that makes patients ...

Catina Pitzen, BSN, RN, of Eisai US, leads Columbus P.ink Day, helping breast cancer survivors transform surgical scars into meaningful tattoo art.